FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2115694552> ?p ?o ?g. }

• W2115694552 endingPage "R13" @default.
• W2115694552 startingPage "R13" @default.
• W2115694552 abstract "We and others have previously shown that antibodies against cyclic citrullinated proteins (anti-CCP) precede the development of rheumatoid arthritis (RA) and in a more recent study we reported that individuals who subsequently developed RA had increased concentrations of several cytokines and chemokines years before the onset of symptoms of joint disease. Here we aimed to evaluate the prevalence and predictive values of anti-CCP antibodies of IgG, IgM and IgA isotype in individuals who subsequently developed RA and also to relate these to cytokines and chemokines, smoking, genetic factors and radiographic score. A case-control study (1:4 ratio) was nested within the Medical Biobank and the Maternity cohorts of Northern Sweden. Patients with RA were identified from blood donors predating the onset of disease by years. Matched controls were selected randomly from the same registers. IgG, IgA and IgM anti-CCP2 antibodies were determined using EliA anti-CCP assay on ImmunoCAP 250 (Phadia AB, Uppsala, Sweden). Of 86 patients with RA identified as blood donors prior to the onset of symptoms, samples were available from 71 for analyses. The median (Q1 to Q3) predating time was 2.5 years (1.1 to 5.9 years). The sensitivity of anti-CCP antibodies in the pre-patient samples was 35.2% for IgG, 23.9% for IgA, and 11.8% for IgM. The presence of IgG and IgA anti-CCP antibodies was highly significant compared with controls. IgG and IgA anti-CCP2 predicted RA significantly in conditional logistic regression models odds ratio (OR) = 94.1, 95% confidence interval (CI) 12.7 to 695.4 and OR = 11.1, 95% CI 4.4 to 28.1, respectively, the IgM anti-CCP showed borderline significance OR = 2.5 95% CI 0.9 to 6.3. Concentrations of all anti-CCP isotypes increased the closer to the onset of symptoms the samples were collected with an earlier and higher increase for IgG and IgA compared with IgM anti-CCP. IgA and IgG anti-CCP positive individuals had different patterns of up-regulated chemokines and also, smoking brought forward the appearance of IgA anti-CCP antibodies in pre-RA individuals. Anti-CCP2 antibodies of both the IgG and IgA isotypes pre-dated the onset of RA by years; also, both IgG and IgA anti-CCP2 antibodies predicted the development of RA, with the highest predictive value for IgG anti-CCP2 antibodies." @default.
• W2115694552 created "2016-06-24" @default.
• W2115694552 creator A5020123243 @default.
• W2115694552 creator A5023228225 @default.
• W2115694552 creator A5028905334 @default.
• W2115694552 creator A5041340587 @default.
• W2115694552 creator A5041771746 @default.
• W2115694552 creator A5084836838 @default.
• W2115694552 creator A5088690481 @default.
• W2115694552 date "2011-01-01" @default.
• W2115694552 modified "2023-10-07" @default.
• W2115694552 title "Antibodies of IgG, IgA and IgM isotypes against cyclic citrullinated peptide precede the development of rheumatoid arthritis" @default.
• W2115694552 cites W1675454661 @default.
• W2115694552 cites W184648558 @default.
• W2115694552 cites W1887388327 @default.
• W2115694552 cites W1980024538 @default.
• W2115694552 cites W1987187864 @default.
• W2115694552 cites W2012130146 @default.
• W2115694552 cites W2023976647 @default.
• W2115694552 cites W2024988150 @default.
• W2115694552 cites W204003194 @default.
• W2115694552 cites W2076345531 @default.
• W2115694552 cites W2102096947 @default.
• W2115694552 cites W2107005433 @default.
• W2115694552 cites W2115608334 @default.
• W2115694552 cites W2124313950 @default.
• W2115694552 cites W2128287735 @default.
• W2115694552 cites W2136894699 @default.
• W2115694552 cites W2141521401 @default.
• W2115694552 cites W2152348310 @default.
• W2115694552 cites W46650105 @default.
• W2115694552 doi "https://doi.org/10.1186/ar3237" @default.
• W2115694552 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3241357" @default.
• W2115694552 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21291540" @default.
• W2115694552 hasPublicationYear "2011" @default.
• W2115694552 type Work @default.
• W2115694552 sameAs 2115694552 @default.
• W2115694552 citedByCount "200" @default.
• W2115694552 countsByYear W21156945522012 @default.
• W2115694552 countsByYear W21156945522013 @default.
• W2115694552 countsByYear W21156945522014 @default.
• W2115694552 countsByYear W21156945522015 @default.
• W2115694552 countsByYear W21156945522016 @default.
• W2115694552 countsByYear W21156945522017 @default.
• W2115694552 countsByYear W21156945522018 @default.
• W2115694552 countsByYear W21156945522019 @default.
• W2115694552 countsByYear W21156945522020 @default.
• W2115694552 countsByYear W21156945522021 @default.
• W2115694552 countsByYear W21156945522022 @default.
• W2115694552 countsByYear W21156945522023 @default.
• W2115694552 crossrefType "journal-article" @default.
• W2115694552 hasAuthorship W2115694552A5020123243 @default.
• W2115694552 hasAuthorship W2115694552A5023228225 @default.
• W2115694552 hasAuthorship W2115694552A5028905334 @default.
• W2115694552 hasAuthorship W2115694552A5041340587 @default.
• W2115694552 hasAuthorship W2115694552A5041771746 @default.
• W2115694552 hasAuthorship W2115694552A5084836838 @default.
• W2115694552 hasAuthorship W2115694552A5088690481 @default.
• W2115694552 hasBestOaLocation W21156945521 @default.
• W2115694552 hasConcept C126322002 @default.
• W2115694552 hasConcept C156957248 @default.
• W2115694552 hasConcept C159654299 @default.
• W2115694552 hasConcept C198451711 @default.
• W2115694552 hasConcept C203014093 @default.
• W2115694552 hasConcept C2776232647 @default.
• W2115694552 hasConcept C2776553844 @default.
• W2115694552 hasConcept C2777077863 @default.
• W2115694552 hasConcept C2777575956 @default.
• W2115694552 hasConcept C2777991845 @default.
• W2115694552 hasConcept C2779102806 @default.
• W2115694552 hasConcept C2780898057 @default.
• W2115694552 hasConcept C542903549 @default.
• W2115694552 hasConcept C71924100 @default.
• W2115694552 hasConceptScore W2115694552C126322002 @default.
• W2115694552 hasConceptScore W2115694552C156957248 @default.
• W2115694552 hasConceptScore W2115694552C159654299 @default.
• W2115694552 hasConceptScore W2115694552C198451711 @default.
• W2115694552 hasConceptScore W2115694552C203014093 @default.
• W2115694552 hasConceptScore W2115694552C2776232647 @default.
• W2115694552 hasConceptScore W2115694552C2776553844 @default.
• W2115694552 hasConceptScore W2115694552C2777077863 @default.
• W2115694552 hasConceptScore W2115694552C2777575956 @default.
• W2115694552 hasConceptScore W2115694552C2777991845 @default.
• W2115694552 hasConceptScore W2115694552C2779102806 @default.
• W2115694552 hasConceptScore W2115694552C2780898057 @default.
• W2115694552 hasConceptScore W2115694552C542903549 @default.
• W2115694552 hasConceptScore W2115694552C71924100 @default.
• W2115694552 hasIssue "1" @default.
• W2115694552 hasLocation W21156945521 @default.
• W2115694552 hasLocation W21156945522 @default.
• W2115694552 hasLocation W21156945523 @default.
• W2115694552 hasLocation W21156945524 @default.
• W2115694552 hasOpenAccess W2115694552 @default.
• W2115694552 hasPrimaryLocation W21156945521 @default.
• W2115694552 hasRelatedWork W163665264 @default.
• W2115694552 hasRelatedWork W1726228667 @default.
• W2115694552 hasRelatedWork W1820541549 @default.
• W2115694552 hasRelatedWork W1900943125 @default.

• next